Zhikun Liu

机构：Hebei Medical University, Fourth Hospital of Hebei Medical University, Hangzhou Medical College · ORCID：0000-0002-2327-6195

发表论文 191 篇 · 总被引 2479 次 · h-index 28

代表论文

• Discovery of a Novel EF24 Analogue-Conjugated Pt(IV) Complex as Multi-Target Pt(IV) Prodrugs Aims to Enhance Anticancer Activity and Overcome Cisplatin Resistance (2025 · Journal of Medicinal Chemistry · 被引 10)
• Application of ATR-FTIR spectroscopy and multivariate statistical analysis in cancer diagnosis (2025 · SLAS TECHNOLOGY · 被引 10)
• Discovery of novel dual tubulin and MMPs inhibitors for the treatment of lung cancer and overcoming drug resistance (2025 · European Journal of Medicinal Chemistry · 被引 7)
• Insulin-induced gene 2 alleviates ischemia-reperfusion injury in steatotic liver by inhibiting GPX4-dependent ferroptosis (2025 · Cell Death Discovery · 被引 6)
• Adjuvant lenvatinib in combination with transarterial chemoembolization for hepatocellular carcinoma patients with high risk of postoperative recurrence: A multicenter prospective cohort study (2025 · Hepatobiliary & pancreatic diseases international · 被引 6)
• Discovery of dual-targeted molecules based on Olaparib and Rigosertib for triple-negative breast cancer with wild-type BRCA (2024 · Bioorganic & Medicinal Chemistry · 被引 6)